Duodenoscope Market By Product Type (Flexible Video Duodenoscopes, Flexible Non-Video Duodenoscopes, Rigid Duodenoscopes, Single-Use Duodenoscopes); By Application (Therapeutic Procedures, Diagnostic Procedures); By Usability (Reusable Duodenoscopes, Disposable Duodenoscopes, Disposable Distal-Cap Duodenoscopes); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Pediatric Centers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Duodenoscope Market Moves Toward Infection-Safe, Procedure-Ready ERCP Platforms

The Global Duodenoscope Market was valued at USD 360 million in 2025 and is projected to reach USD 550 million by 2032, growing at a CAGR of 6.40% during 2026–2032, according to Strategic Market Research.

 

A duodenoscope is a specialized flexible endoscope used mainly for endoscopic retrograde cholangiopancreatography (ERCP), a minimally invasive procedure that allows doctors to examine and treat problems in the bile ducts and pancreatic ducts. Unlike standard endoscopes, duodenoscopes have a side-viewing design and a movable elevator mechanism that helps physicians guide instruments precisely during complex procedures.

 

Duodenoscopes are widely used by gastroenterologists to treat conditions such as bile duct stones, blocked ducts, tumors, strictures, and pancreatic disorders. Common procedures include stone removal, tissue sampling, bile drainage, sphincterotomy, and stent placement. The U.S. FDA estimates that more than 500,000 ERCP procedures are performed annually in the United States, creating continuous demand for duodenoscopes, accessories, repair services, and infection-control solutions.

 

Recent innovations are focused on enhancing infection prevention, procedural efficiency, and physician usability. The Boston Scientific EXALT Model D Generation 4 improves maneuverability and control through a disposable design, eliminating patient-to-patient contamination risks associated with reusable devices. FUJIFILM ED-840T incorporates high-resolution imaging, a larger working channel, and design improvements for hepatobiliary procedures. Olympus TJF-Q190V and PENTAX Medical I-DEC incorporate disposable distal-end or elevator components to simplify cleaning and reduce contamination risks.

 

Overall, the duodenoscope market is shifting from a traditional reusable device model toward a safer, infection-conscious, and value-driven endoscopy ecosystem. Future growth will depend on balancing infection prevention, procedural efficiency, healthcare costs, and technological innovation as hospitals increasingly prioritize safer ERCP solutions and advanced endoscopic care pathways.

 

Complete Segment Snapshot Across Product Type, Application, Usability, End User, and Geography in the Duodenoscope Market

By Product Type

• Flexible video duodenoscopes lead the product category with a 55% share and USD 198 million in 2025 because digital imaging and accessory control are central to modern ERCP.

• Flexible non-video duodenoscopes hold an 18% share and USD 65 million, serving cost-sensitive facilities with basic visualization requirements.

• Rigid duodenoscopes represent 7% of the market and USD 25 million, reflecting their restricted role in complex pancreaticobiliary procedures.

• Single-use duodenoscopes account for 20% and USD 72 million and form the fastest-growing product category as hospitals seek to eliminate scope-related reprocessing exposure.

 

By Application

• Therapeutic procedures dominate with a 75% share and USD 270 million because ERCP is widely used for stone extraction, drainage, stent placement, and stricture management.

• Diagnostic procedures represent 25% and USD 90 million, covering ductal evaluation, cholangiography, tissue acquisition, and assessment before intervention.

 

By Usability

• Reusable duodenoscopes remain the largest usability category with a 62% share and USD 223 million due to their established installed base and economics in high-volume centers.

• Disposable duodenoscopes hold a 23% share and USD 83 million and offer a sterile device for each patient without post-procedure scope reprocessing.

• Disposable distal-cap duodenoscopes account for 15% and USD 54 million, combining reusable-scope economics with easier access to contamination-prone distal components.

 

By End User

• Hospitals lead with a 70% share and USD 252 million because they manage the largest ERCP volumes and the most complex pancreaticobiliary cases.

• Ambulatory surgical centers represent 15% and USD 54 million as selected ERCP procedures move into appropriately equipped outpatient environments.

• Specialty clinics hold a 10% share and USD 36 million through focused gastroenterology and pancreaticobiliary services.

• Pediatric centers account for 5% and USD 18 million, reflecting a smaller but specialized procedural population requiring suitable equipment and clinical expertise.

 

By Geography

• North America leads with a 38% share and USD 137 million through high ERCP utilization, developed endoscopy infrastructure, and early adoption of infection-control technologies.

• Europe accounts for 30% and USD 108 million, with procurement balancing clinical performance, reprocessing safety, lifecycle cost, and sustainability.

• Asia Pacific holds a 22% share and USD 79 million and is the fastest-growing region as therapeutic endoscopy capacity expands.

• Latin America represents 6% and USD 22 million, led by tertiary hospitals, private networks, and urban specialty centers.

• Middle East & Africa accounts for 4% and USD 14 million, with adoption concentrated in countries investing in advanced gastrointestinal care.

 

Product Design, Therapeutic Demand, and Care-Setting Economics Define Segment Leadership in the Duodenoscope Market

By Product Type

Flexible video duodenoscopes are the leading product segment, accounting for approximately 55% of the market and USD 198 million in 2025. The segment’s position is supported by the importance of high-resolution visualization, stable scope control, responsive forceps elevators, and compatibility with guidewires, extraction devices, biopsy tools, and stents during ERCP. Hospitals also favor video platforms that integrate with established processors, documentation systems, training programs, and service contracts. Products from Olympus, Fujifilm, and PENTAX Medical strengthen this segment through advanced imaging and therapeutic-channel capabilities. The segment is projected to expand at a CAGR of 6.2% during 2026–2032.

Single-use duodenoscopes are the fastest-growing product segment, holding approximately 20% of the market and USD 72 million in 2025. The segment is projected to expand at a CAGR of 9.2% during 2026–2032. Each procedure uses a new sterile scope, eliminating patient-to-patient transmission associated with ineffective duodenoscope reprocessing. Single-use products also avoid cleaning, high-level disinfection, maintenance, repair, drying, and contamination-related quarantine. Boston Scientific’s EXALT Model D supports this transition by offering a fully disposable platform designed to reproduce the handling and visualization expected from reusable devices. Adoption is particularly relevant for high-risk patients, urgent procedures, outbreak-response protocols, and facilities with limited reprocessing capacity.

 

By Application

Therapeutic procedures are both the leading and fastest-growing application segment, representing approximately 75% of the market and USD 270 million in 2025. The segment is projected to expand at a CAGR of 6.7% during 2026–2032, compared with 5.4% for diagnostic procedures. ERCP is increasingly used as an interventional procedure rather than solely as a diagnostic examination. Its major applications include bile-duct stone extraction, sphincterotomy, biliary drainage, stricture dilation, pancreatic intervention, and stent placement.

The commercial value of therapeutic procedures extends beyond the duodenoscope itself. Each intervention may require guidewires, extraction balloons, baskets, sphincterotomes, dilation devices, biopsy tools, and biliary or pancreatic stents. Manufacturers with integrated ERCP portfolios, including Boston Scientific, Olympus, Fujifilm, and PENTAX Medical, can therefore capture recurring accessory revenue alongside scope and processor sales. Diagnostic ERCP remains clinically relevant, but non-invasive imaging and endoscopic ultrasound have reduced its use for diagnosis-only cases.

 

By Usability

Reusable duodenoscopes are the leading usability segment, accounting for approximately 62% of the market and USD 223 million in 2025. The segment is projected to grow at a CAGR of 5.3% during 2026–2032. Reusable systems remain economically attractive to high-volume hospitals because their acquisition cost can be distributed across numerous procedures. They also benefit from an established installed base, physician familiarity, processor compatibility, mature repair services, and integration with hospital reprocessing departments.

Their purchase price, however, does not represent the complete cost of ownership. Hospitals must also account for manual cleaning, automated high-level disinfection, drying, storage, maintenance, repairs, microbiological surveillance, and replacement capacity during scope downtime. Reusable devices will therefore remain dominant, but hospitals are increasingly selecting newer models with removable distal covers or disposable elevator components instead of older fixed-endcap designs.

Disposable duodenoscopes are the fastest-growing usability segment, holding approximately 23% of the market and USD 83 million in 2025. The segment is forecast to expand at a CAGR of 9.0% during 2026–2032. Their principal advantage is the availability of a sterile, procedure-ready instrument without post-procedure scope reprocessing. This model reduces workflow dependence on sterile-processing capacity and provides predictable availability when reusable scopes are under repair, quarantined, or awaiting surveillance results. Wider adoption will depend on whether avoided reprocessing and maintenance expenses can offset the higher device cost per procedure.

 

By End User

Hospitals are the leading end-user segment, representing approximately 70% of the market and USD 252 million in 2025. The segment is projected to expand at a CAGR of 6.1% during 2026–2032. Hospitals perform the largest ERCP volumes and treat complex conditions such as acute biliary obstruction, cholangitis, difficult bile-duct stones, malignant strictures, and pancreatic-duct disorders. These cases often require fluoroscopy, anesthesia, pathology, surgery, intensive care, and interventional radiology support, reinforcing the role of hospital-based endoscopy departments.

Hospitals also account for substantial spending on imaging processors, reusable scopes, single-use devices, distal caps, endotherapy accessories, maintenance agreements, and reprocessing infrastructure. Large facilities may maintain mixed inventories, using reusable scopes for routine high-volume procedures and single-use devices for infection-sensitive patients, emergency cases, or periods of reusable-scope downtime.

Ambulatory surgical centers are the fastest-growing end-user segment, accounting for approximately 15% of the market and USD 54 million in 2025. The segment is expected to expand at a CAGR of 7.0% during 2026–2032. Growth reflects the movement of appropriately selected minimally invasive gastrointestinal procedures into outpatient settings, where shorter stays and streamlined workflows can reduce the total cost of care.

Duodenoscope adoption in these centers depends on patient selection, ERCP-trained clinicians, anesthesia support, fluoroscopy access, recovery capacity, and hospital-transfer arrangements. Single-use scopes may be particularly relevant to lower-volume centers because they reduce the need for extensive reprocessing infrastructure and provide a procedure-ready device without maintaining a large reusable inventory.

 

By Geography

North America is the leading regional market, accounting for approximately 38% of global revenue and USD 137 million in 2025. The region is projected to expand at a CAGR of 6.1% during 2026–2032. Its leadership is supported by more than 500,000 annual ERCP procedures in the United States, developed gastroenterology infrastructure, strong medical-device presence, and early adoption of redesigned duodenoscopes.

FDA scrutiny of duodenoscope-associated infections has accelerated replacement of older fixed-endcap devices with fully disposable systems and reusable products containing disposable components. North American hospitals also have access to platforms from Boston Scientific, Olympus, Fujifilm, and PENTAX Medical, allowing procurement teams to compare reusable, hybrid, and single-use operating models.

Asia Pacific is the fastest-growing regional market, representing approximately 22% of global revenue and USD 79 million in 2025. The region is projected to expand at a CAGR of 8.0% during 2026–2032. Expansion of tertiary hospitals, fluoroscopy capacity, specialist gastroenterology services, and ERCP training is widening access to therapeutic pancreaticobiliary procedures.

Japan provides an important manufacturing and innovation base through Olympus, Fujifilm, and HOYA–PENTAX Medical. High-volume hospitals across Japan, China, South Korea, India, and other regional markets are investing in integrated video endoscopy systems and therapeutic accessories. Reusable products are expected to remain commercially important because of cost considerations, while disposable and hybrid designs will gain adoption in premium hospitals and facilities prioritizing infection control.

 

Installed-Base Scale and Single-Use Innovation Define Competitive Leadership in the Duodenoscope Market

Olympus Corporation — Overall Market Leader

Olympus is the leading company due to its extensive gastrointestinal endoscopy installed base, strong physician familiarity, global service network, imaging processors, endotherapy accessories, and reusable duodenoscope portfolio. Its TJF-Q190V combines established reusable-scope economics with a sterile single-use distal cover, improved distal-end access, and a flushing adapter designed to support reprocessing. This integrated product-and-service ecosystem gives Olympus the strongest overall competitive position.

Boston Scientific Corporation — Leader in Single-Use Duodenoscopes

Boston Scientific is a leading competitor through its EXALT Model D, a fully single-use duodenoscope supplied sterile for each procedure. The platform eliminates patient-to-patient transmission associated with ineffective scope reprocessing and targets hospitals seeking procedure-ready availability. Boston Scientific also offers guidewires, sphincterotomes, extraction devices, dilation products, and stents, allowing it to compete across the complete ERCP workflow.

Fujifilm Holdings Corporation — Leading Imaging-Based Competitor

Fujifilm ranks among the leading companies through its reusable video duodenoscopes and integrated ELUXEO imaging platform. Its ED-840T includes high-resolution imaging, a redesigned distal configuration, and a 4.5-mm working channel for complex hepatopancreatobiliary interventions. Fujifilm is particularly competitive among hospitals already using its processors and seeking advanced therapeutic performance without moving entirely to disposable scopes.

Other Important but Not Leading Companies

• HOYA Corporation–PENTAX Medical: PENTAX Medical is an important hybrid-technology competitor through its I-DEC duodenoscope with a disposable elevator cap, but its market reach and installed-base strength are comparatively narrower than those of the three leaders.

• Ambu: Ambu is a notable single-use endoscopy innovator with procedure-ready disposable technology, but it does not currently match the broader duodenoscope portfolios, ERCP accessory depth, or established hospital presence of Olympus, Boston Scientific, and Fujifilm.

 

Reusable, Hybrid, and Single-Use ERCP Models Reshape Future Market Value

The future growth of the Duodenoscope Market will be driven by the shift from traditional endoscope replacement toward safer, more efficient, and economically optimized ERCP ecosystems. While reusable duodenoscopes will remain essential in high-volume centers, increasing attention toward infection prevention, operational efficiency, and regulatory expectations will accelerate adoption of hybrid platforms with disposable components and fully single-use duodenoscopes. Manufacturers that can deliver improved safety without compromising image quality, maneuverability, and procedural reliability will gain stronger market positioning.

A major commercial opportunity lies in addressing the total cost of ERCP delivery rather than device acquisition alone. Hospitals are increasingly evaluating the complete economic impact of duodenoscope use, including reprocessing requirements, sterilization infrastructure, repair costs, scope downtime, infection surveillance, and procedure delays. Companies offering integrated solutions that combine scopes, processors, accessories, service agreements, and infection-control technologies can create stronger value propositions and recurring revenue opportunities.

The expansion of therapeutic endoscopy infrastructure in emerging markets represents another important growth opportunity. Rising healthcare investments, increasing gastrointestinal disease burden, and the development of specialized endoscopy centers across Asia Pacific, Latin America, and the Middle East are expected to increase demand for advanced ERCP technologies. However, successful adoption will depend on addressing affordability, training requirements, maintenance support, and local healthcare infrastructure limitations.

Future innovation will increasingly focus on digital integration and smarter endoscopy workflows. Artificial intelligence-assisted imaging, automated documentation, connectivity with hospital information systems, predictive maintenance, and improved procedural analytics may transform duodenoscopes from standalone visualization devices into connected procedural platforms. These advancements could improve efficiency, standardize care, and support better clinical decision-making.

The market is also expected to evolve toward a risk-based technology model, where reusable, hybrid, and disposable systems coexist depending on procedure complexity, infection risk, hospital volume, and economic priorities. High-risk or low-volume procedures may favor single-use devices, while established ERCP centers may continue using advanced reusable platforms with improved reprocessing solutions.

Overall, the duodenoscope market is moving toward a future defined by infection safety, operational efficiency, and integrated procedural care. The strongest commercial opportunities will emerge for companies that can reduce contamination risk, simplify workflows, expand access to advanced ERCP, and provide economically sustainable solutions for healthcare providers worldwide.

 

Duodenoscope Market Report Coverage Table

Report Attribute	Details
Forecast Period	2026 – 2032
Market Size Value in 2025	USD 360 Million
Revenue Forecast in 2032	USD 550 Million
Overall Growth Rate	CAGR of 6.40% (2026 – 2032)
Base Year for Estimation	2025
Historical Data	2019 – 2024
Unit	USD Million, CAGR (2026 – 2032)
Segmentation	By Product Type, By Application, By Usability, By End User, By Geography
By Product Type	Flexible Video Duodenoscopes, Flexible Non-Video Duodenoscopes, Rigid Duodenoscopes, Single-Use Duodenoscopes
By Application	Therapeutic Procedures, Diagnostic Procedures
By Usability	Reusable Duodenoscopes, Disposable Duodenoscopes, Disposable Distal-Cap Duodenoscopes
By End User	Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Pediatric Centers
By Region	North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Country Scope	U.S., Canada, UK, Germany, France, Italy, Spain, Japan, China, South Korea, India, Australia, Brazil, Mexico, Saudi Arabia, UAE, South Africa
Market Drivers	High ERCP procedure volumes, growing demand for infection-safe endoscopy, adoption of single-use and disposable-component platforms, expansion of therapeutic pancreaticobiliary procedures, and investment in advanced endoscopy infrastructure across emerging markets
Customization Option	Available upon request